Skip to main content

Table 3 Prevalence of Neonatal Outcomes According to Quartiles of Total Caffeine Intake in the Norwegian Mother and Child Cohort Study, 2002–2009

From: Caffeine exposure during pregnancy, small for gestational age birth and neonatal outcome – results from the Norwegian Mother and Child Cohort Study

  

Low caffeine intake (< 23 mg/day)

Medium caffeine intake (23–58 mg/day)

High caffeine intake (59–123 mg/day)

Very high caffeine intake (> 123 mg/day)

 

n total

16,893

16,892

16,892

16,892

Neonatal morbidity/mortality

no

65,445

16,356

16,349

16,362

16,378

n (%)

(97)

(97)

(97)

(97)

(97)

yes

2124

537

543

530

514

n (%)

(3)

(3)

(3)

(3)

(3)

Neonatal intervention

no

58,319

14,559

14,591

14,570

14,599

n (%)

(86)

(86)

(86)

(86)

(86)

yes

9250

2334

2301

2322

2293

n (%)

(14)

(14)

(14)

(14)

(14)